{"title":"The effects of different carbon-fiber plate shapes in shoes on lower limb biomechanics following running-induced fatigue.","authors":"Yufan Xu, Chengyuan Zhu, Yufei Fang, Zhenghui Lu, Yang Song, Chen Hu, Dong Sun, Yaodong Gu","doi":"10.3389/fbioe.2025.1539976","DOIUrl":null,"url":null,"abstract":"<p><p>Different shapes of carbon-fiber plates (CFPs) are likely to affect lower limb biomechanics, particularly under conditions of running-induced fatigue, and potentially impact runners' performance and risk of injury. However, no studies have yet elucidated the precise effects of CFP shapes on the lower limb biomechanical characteristics subsequent to running-induced fatigue. The purpose of this study was to investigate the effects of different CFP shapes in running shoes on the lower limb biomechanics of runners following running-induced fatigue. 12 male runners (aged 21.8 ± 1.3 years, mass 59.1 ± 4.1 kg, height 168.9 ± 2.2 cm, weekly running distance 68.8 ± 5.5 km/week) were recruited for this study. Two-way repeated measures ANOVA was used to compare kinematic and kinetic data, while SPM (Statistical Parametric Mapping) was used to assess the activation levels of lower limb muscles. Compared to wearing flat CFP shoes (\"Flat\"), wearing curved CFP shoes (\"Curve\") resulted in a significant reduction in the hip (p = 0.034) and knee contact angle (p < 0.000), as well as a significant decrease in the hip flexion moment (p = 0.008). The activation level of the tibialis anterior (TA) was significantly higher when wearing \"Curve\" in pre-fatigue compared to \"Flat\", whereas the opposite was observed post-fatigue. The curved CFP altered the bending angle of the forefoot, thereby significantly reducing the joint angles and joint moments of the hip and knee.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"13 ","pages":"1539976"},"PeriodicalIF":4.3000,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11850346/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2025.1539976","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Different shapes of carbon-fiber plates (CFPs) are likely to affect lower limb biomechanics, particularly under conditions of running-induced fatigue, and potentially impact runners' performance and risk of injury. However, no studies have yet elucidated the precise effects of CFP shapes on the lower limb biomechanical characteristics subsequent to running-induced fatigue. The purpose of this study was to investigate the effects of different CFP shapes in running shoes on the lower limb biomechanics of runners following running-induced fatigue. 12 male runners (aged 21.8 ± 1.3 years, mass 59.1 ± 4.1 kg, height 168.9 ± 2.2 cm, weekly running distance 68.8 ± 5.5 km/week) were recruited for this study. Two-way repeated measures ANOVA was used to compare kinematic and kinetic data, while SPM (Statistical Parametric Mapping) was used to assess the activation levels of lower limb muscles. Compared to wearing flat CFP shoes ("Flat"), wearing curved CFP shoes ("Curve") resulted in a significant reduction in the hip (p = 0.034) and knee contact angle (p < 0.000), as well as a significant decrease in the hip flexion moment (p = 0.008). The activation level of the tibialis anterior (TA) was significantly higher when wearing "Curve" in pre-fatigue compared to "Flat", whereas the opposite was observed post-fatigue. The curved CFP altered the bending angle of the forefoot, thereby significantly reducing the joint angles and joint moments of the hip and knee.
期刊介绍:
The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.
In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.